1 Subcutaneous Immunoglobulins Market Overview 1.1 Product Overview and Scope of Subcutaneous Immunoglobulins 1.2 Subcutaneous Immunoglobulins Segment by Purity 1.2.1 Global Subcutaneous Immunoglobulins Sales Growth Rate Comparison by Purity (2022-2028) 1.2.2 0.1 1.2.3 0.2 1.3 Subcutaneous Immunoglobulins Segment by Application 1.3.1 Global Subcutaneous Immunoglobulins Sales Comparison by Application: (2022-2028) 1.3.2 Primary Immunodeficiency 1.3.3 Secondary Immunodeficiency 1.3.4 Others 1.4 Global Subcutaneous Immunoglobulins Market Size Estimates and Forecasts 1.4.1 Global Subcutaneous Immunoglobulins Revenue 2017-2028 1.4.2 Global Subcutaneous Immunoglobulins Sales 2017-2028 1.4.3 Subcutaneous Immunoglobulins Market Size by Region: 2017 Versus 2021 Versus 2028 2 Subcutaneous Immunoglobulins Market Competition by Manufacturers 2.1 Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturers (2017-2022) 2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Subcutaneous Immunoglobulins Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Subcutaneous Immunoglobulins Manufacturing Sites, Area Served, Product Type 2.5 Subcutaneous Immunoglobulins Market Competitive Situation and Trends 2.5.1 Subcutaneous Immunoglobulins Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Subcutaneous Immunoglobulins Players Market Share by Revenue 2.5.3 Global Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Subcutaneous Immunoglobulins Retrospective Market Scenario by Region 3.1 Global Subcutaneous Immunoglobulins Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Subcutaneous Immunoglobulins Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Subcutaneous Immunoglobulins Market Facts & Figures by Country 3.3.1 North America Subcutaneous Immunoglobulins Sales by Country 3.3.2 North America Subcutaneous Immunoglobulins Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Subcutaneous Immunoglobulins Market Facts & Figures by Country 3.4.1 Europe Subcutaneous Immunoglobulins Sales by Country 3.4.2 Europe Subcutaneous Immunoglobulins Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Subcutaneous Immunoglobulins Market Facts & Figures by Region 3.5.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Region 3.5.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Subcutaneous Immunoglobulins Market Facts & Figures by Country 3.6.1 Latin America Subcutaneous Immunoglobulins Sales by Country 3.6.2 Latin America Subcutaneous Immunoglobulins Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Subcutaneous Immunoglobulins Market Facts & Figures by Country 3.7.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country 3.7.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Subcutaneous Immunoglobulins Historic Market Analysis by Purity 4.1 Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2022) 4.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2022) 4.3 Global Subcutaneous Immunoglobulins Price by Purity (2017-2022) 5 Global Subcutaneous Immunoglobulins Historic Market Analysis by Application 5.1 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2022) 5.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2022) 5.3 Global Subcutaneous Immunoglobulins Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Shire (Baxalta) 6.1.1 Shire (Baxalta) Corporation Information 6.1.2 Shire (Baxalta) Description and Business Overview 6.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Product Portfolio 6.1.5 Shire (Baxalta) Recent Developments/Updates 6.2 Grifols 6.2.1 Grifols Corporation Information 6.2.2 Grifols Description and Business Overview 6.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Grifols Subcutaneous Immunoglobulins Product Portfolio 6.2.5 Grifols Recent Developments/Updates 6.3 CSL 6.3.1 CSL Corporation Information 6.3.2 CSL Description and Business Overview 6.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2017-2022) 6.3.4 CSL Subcutaneous Immunoglobulins Product Portfolio 6.3.5 CSL Recent Developments/Updates 7 Subcutaneous Immunoglobulins Manufacturing Cost Analysis 7.1 Subcutaneous Immunoglobulins Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Subcutaneous Immunoglobulins 7.4 Subcutaneous Immunoglobulins Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Subcutaneous Immunoglobulins Distributors List 8.3 Subcutaneous Immunoglobulins Customers 9 Subcutaneous Immunoglobulins Market Dynamics 9.1 Subcutaneous Immunoglobulins Industry Trends 9.2 Subcutaneous Immunoglobulins Market Drivers 9.3 Subcutaneous Immunoglobulins Market Challenges 9.4 Subcutaneous Immunoglobulins Market Restraints 10 Global Market Forecast 10.1 Subcutaneous Immunoglobulins Market Estimates and Projections by Purity 10.1.1 Global Forecasted Sales of Subcutaneous Immunoglobulins by Purity (2023-2028) 10.1.2 Global Forecasted Revenue of Subcutaneous Immunoglobulins by Purity (2023-2028) 10.2 Subcutaneous Immunoglobulins Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Subcutaneous Immunoglobulins by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Subcutaneous Immunoglobulins by Application (2023-2028) 10.3 Subcutaneous Immunoglobulins Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Subcutaneous Immunoglobulins by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Subcutaneous Immunoglobulins by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Subcutaneous Immunoglobulins Sales Growth Rate Comparison by Purity (2022-2028) & (K Bottle) & (US$ Million) Table 2. Global Subcutaneous Immunoglobulins Sales Growth Rate Comparison by Application (2022-2028) & (K Bottle) & (US$ Million) Table 3. Global Subcutaneous Immunoglobulins Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Subcutaneous Immunoglobulins Market Competitive Situation by Manufacturers in 2021 Table 5. Global Subcutaneous Immunoglobulins Sales (K Bottle) of Key Manufacturers (2017-2022) Table 6. Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturers (2017-2022) Table 7. Global Subcutaneous Immunoglobulins Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Subcutaneous Immunoglobulins Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Subcutaneous Immunoglobulins Average Price (USD/Bottle) of Key Manufacturers (2017-2022) Table 10. Manufacturers Subcutaneous Immunoglobulins Manufacturing Sites and Area Served Table 11. Manufacturers Subcutaneous Immunoglobulins Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Subcutaneous Immunoglobulins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Immunoglobulins as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Subcutaneous Immunoglobulins Sales by Region (2017-2022) & (K Bottle) Table 16. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2017-2022) Table 17. Global Subcutaneous Immunoglobulins Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2017-2022) Table 19. North America Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle) Table 20. North America Subcutaneous Immunoglobulins Sales Market Share by Country (2017-2022) Table 21. North America Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Subcutaneous Immunoglobulins Revenue Market Share by Country (2017-2022) Table 23. Europe Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle) Table 24. Europe Subcutaneous Immunoglobulins Sales Market Share by Country (2017-2022) Table 25. Europe Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Subcutaneous Immunoglobulins Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Subcutaneous Immunoglobulins Sales by Region (2017-2022) & (K Bottle) Table 28. Asia Pacific Subcutaneous Immunoglobulins Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Subcutaneous Immunoglobulins Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Subcutaneous Immunoglobulins Revenue Market Share by Region (2017-2022) Table 31. Latin America Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle) Table 32. Latin America Subcutaneous Immunoglobulins Sales Market Share by Country (2017-2022) Table 33. Latin America Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Subcutaneous Immunoglobulins Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle) Table 36. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Country (2017-2022) Table 39. Global Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle) Table 40. Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2022) Table 41. Global Subcutaneous Immunoglobulins Revenue by Purity (2017-2022) & (US$ Million) Table 42. Global Subcutaneous Immunoglobulins Revenue Share by Purity (2017-2022) Table 43. Global Subcutaneous Immunoglobulins Price by Purity (2017-2022) & (USD/Bottle) Table 44. Global Subcutaneous Immunoglobulins Sales (K Bottle) by Application (2017-2022) Table 45. Global Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2022) Table 46. Global Subcutaneous Immunoglobulins Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Subcutaneous Immunoglobulins Revenue Share by Application (2017-2022) Table 48. Global Subcutaneous Immunoglobulins Price by Application (2017-2022) & (USD/Bottle) Table 49. Shire (Baxalta) Corporation Information Table 50. Shire (Baxalta) Description and Business Overview Table 51. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022) Table 52. Shire (Baxalta) Subcutaneous Immunoglobulins Product Table 53. Shire (Baxalta) Recent Developments/Updates Table 54. Grifols Corporation Information Table 55. Grifols Description and Business Overview Table 56. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022) Table 57. Grifols Subcutaneous Immunoglobulins Product Table 58. Grifols Recent Developments/Updates Table 59. CSL Corporation Information Table 60. CSL Description and Business Overview Table 61. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022) Table 62. CSL Subcutaneous Immunoglobulins Product Table 63. CSL Recent Developments/Updates Table 64. Production Base and Market Concentration Rate of Raw Material Table 65. Key Suppliers of Raw Materials Table 66. Subcutaneous Immunoglobulins Distributors List Table 67. Subcutaneous Immunoglobulins Customers List Table 68. Subcutaneous Immunoglobulins Market Trends Table 69. Subcutaneous Immunoglobulins Market Drivers Table 70. Subcutaneous Immunoglobulins Market Challenges Table 71. Subcutaneous Immunoglobulins Market Restraints Table 72. Global Subcutaneous Immunoglobulins Sales Forecast by Purity (2023-2028) & (K Bottle) Table 73. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Purity (2023-2028) Table 74. Global Subcutaneous Immunoglobulins Revenue Forecast by Purity (2023-2028) & (US$ Million) Table 75. Global Subcutaneous Immunoglobulins Revenue Market Share Forecast by Purity (2023-2028) Table 76. Global Subcutaneous Immunoglobulins Sales Forecast by Application (2023-2028) & (K Bottle) Table 77. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Application (2023-2028) Table 78. Global Subcutaneous Immunoglobulins Revenue Forecast by Application (2023-2028) & (US$ Million) Table 79. Global Subcutaneous Immunoglobulins Revenue Market Share Forecast by Application (2023-2028) Table 80. Global Subcutaneous Immunoglobulins Sales Forecast by Region (2023-2028) & (K Bottle) Table 81. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Region (2023-2028) Table 82. Global Subcutaneous Immunoglobulins Revenue Forecast by Region (2023-2028) & (US$ Million) Table 83. Global Subcutaneous Immunoglobulins Revenue Market Share Forecast by Region (2023-2028) Table 84. Research Programs/Design for This Report Table 85. Key Data Information from Secondary Sources Table 86. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Subcutaneous Immunoglobulins Figure 2. Global Subcutaneous Immunoglobulins Market Share by Purity in 2021 & 2028 Figure 3. 0.1 Product Picture Figure 4. 0.2 Product Picture Figure 5. Global Subcutaneous Immunoglobulins Market Share by Application in 2021 & 2028 Figure 6. Primary Immunodeficiency Figure 7. Secondary Immunodeficiency Figure 8. Others Figure 9. Global Subcutaneous Immunoglobulins Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Subcutaneous Immunoglobulins Market Size (2017-2028) & (US$ Million) Figure 11. Global Subcutaneous Immunoglobulins Sales (2017-2028) & (K Bottle) Figure 12. Subcutaneous Immunoglobulins Sales Share by Manufacturers in 2021 Figure 13. Global Subcutaneous Immunoglobulins Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Subcutaneous Immunoglobulins Players: Market Share by Revenue in 2021 Figure 15. Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2017-2022) Figure 17. Global Subcutaneous Immunoglobulins Sales Market Share by Region in 2021 Figure 18. Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2017-2022) Figure 19. Global Subcutaneous Immunoglobulins Revenue Market Share by Region in 2021 Figure 20. U.S. Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. China Taiwan Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Mexico Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Brazil Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Argentina Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Turkey Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Saudi Arabia Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. UAE Subcutaneous Immunoglobulins Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Sales Market Share of Subcutaneous Immunoglobulins by Purity (2017-2022) Figure 43. Manufacturing Cost Structure of Subcutaneous Immunoglobulins Figure 44. Manufacturing Process Analysis of Subcutaneous Immunoglobulins Figure 45. Subcutaneous Immunoglobulins Industrial Chain Analysis Figure 46. Channels of Distribution Figure 47. Distributors Profiles Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Shire (Baxalta) Grifols CSL